Trials / Sponsors / Shanghai Kanda Biotechnology Co., Ltd.
Shanghai Kanda Biotechnology Co., Ltd.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | KD6001 in Combination With Anti-PD-1 Antibody±Bevacizumab in Patients With Advanced HCC and Other Solid Tumors Advanced HCC, Other Solid Tumors | Phase 1 / Phase 2 | 2024-04-15 |
| Completed | A Study of KD6005 in Healthy Participants and Participants With Rheumatoid Arthritis (RA) Rheumatoid Arthritis | Phase 1 | 2024-01-06 |
| Unknown | KD6001 in Combination With Anti-PD-1 Antibody in Patients With Advanced Melanoma Melanoma | Phase 1 / Phase 2 | 2023-03-22 |
| Completed | Clinical Study of KD6001 in Advanced Solid Tumours Solid Tumor | Phase 1 | 2020-09-10 |